您所在的位置:首頁 > 腎內(nèi)科診療指南 > 2010CARI2型糖尿病患者的腎功能評估
《2010CARI2型糖尿病患者的腎功能評估》內(nèi)容簡介:
This guideline topic has been taken from the NHMRC'National Evidence Based Guidelines for Diagnosis, Preven-tion and Management of CKD in type 2 diabetes' whichcan be found in full at the CARI website (http://www.cari.org.au)。 The NHMRC guideline covers issuesrelated to the assessment and prevention of CKD in indi-viduals with established type 2 diabetes.
《2010CARI2型糖尿病患者的腎功能評估》內(nèi)容預覽:
The NHMRCguidelines do not address the care of people with diabeteswho have end-stage kidney disease (ESKD) or those whohave a functional renal transplant. In addition, the presentguideline does not provide recommendations regarding themanagement of individuals with established CKD, withrespect to the prevention of other (non-renal) adverse out-comes, including retinopathy, hypoglycaemia, bone diseaseand cardiovascular disease. It is important to note however,that in an individual with type 2 diabetes, the prevention ofthese complications may be a more important determinantfor their clinical care. Consequently, the recommendationsmade must be balanced against the overall managementneeds of each individual patient.
There is a high intra-individual variability in 24 halbumin excretion with a coefficient of variation of 40-50%,therefore a diagnosis of persistent microalbuminuria shouldbe based on repeated measurements, especially if long-termtreatment of normotensive individuals are being considered.While increasing albuminuria is a risk factor for both CVDand ESKD, cross sectional studies have also shown a highdegree of heterogeneity in people with type 2 diabetes com-pared with type 1 diabetes with respect to CKD. As such asignificant proportion of people with type 2 diabetes mayhave CKD and be normoalbuminuric.3,6,7In the recentlyreported ARIC study (a population based prospective bira-cial long-term observational study of 2187 individuals withpredominantly type 2 diabetes), 30% of incident CKD(defined as eGFR < 60 mL/min per 1.73 m2or kidneydisease at hospitalization) did not have albuminuria(ACR 3 30 mg/g)。
點擊下載***:《2010CARI2型糖尿病患者的腎功能評估》
腎臟亦是參與機體代謝的器官之一,尤其是在水、電解質(zhì)與酸堿平衡的維持,代謝中...[詳細]
造影劑腎病是碘造影劑應用過程中的重要并發(fā)癥,也是醫(yī)源性腎功能衰竭的重要組成...[詳細]
意見反饋 關(guān)于我們 隱私保護 版權(quán)聲明 友情鏈接 聯(lián)系我們
Copyright 2002-2024 Iiyi.Com All Rights Reserved